Cancer clinical trial participants reimbursed a median $2,128 for nonmedical expenses

New research reveals that participating in cancer clinical trials can cause financial burdens that are shaped by both socioeconomic and logistical factors. The analysis published by Wiley online in CANCER, indicates the need for better reimbursement programs to improve equitable access to, and retention in, cancer clinical trials.